In various prostate cancer cell lines (such as 22RV1, C4-2, DU145, LNCaP, and PC-3), as well as benign prostate hyperplasia cell line RWPE-1, we examined PUS1 expression using qPCR and Western blot. Here, PUS1 is linked to prostate carcinoma.